AI-generated summary
This review examines treatment options for androgenetic alopecia, weighing efficacy, side effects, compliance, cost, and ethics. The authors report that topical minoxidil, oral finasteride, and low-level light therapy are the only FDA-approved therapies, while many other options are available. The authors note that selecting treatment is challenging and should reflect each patient's needs and goals.
- Who or what was studied
- Individuals with androgenetic alopecia (men and women)
- Limits stated in the abstract
- The abstract describes a literature search supplemented by the authors' and other practitioners' clinical experience, without reporting a systematic method or quantified efficacy results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.